Cite
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom.
MLA
Minson, Adrian, et al. “Death from Mantle Cell Lymphoma Limits Sequential Therapy, Particularly after First Relapse: Patterns of Care and Outcomes in a Series from Australia and the United Kingdom.” British Journal of Haematology, vol. 204, no. 2, Feb. 2024, pp. 548–54. EBSCOhost, https://doi.org/10.1111/bjh.19179.
APA
Minson, A., Hamad, N., Di, C. P., Talaulikar, D., Ku, M., Ratnasingam, S., Cheah, C., Yannakou, C. K., Bishton, M., Ng, Z. Y., Agrawal, S., McQuillan, A., Johnston, A., Choong, E., Wong, K., McQuillan, J., Beekman, A., Hawkes, E., & Dickinson, M. (2024). Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom. British Journal of Haematology, 204(2), 548–554. https://doi.org/10.1111/bjh.19179
Chicago
Minson, Adrian, Nada Hamad, Ciaccio, Pietro Di, Dipti Talaulikar, Matthew Ku, Sumita Ratnasingam, Chan Cheah, et al. 2024. “Death from Mantle Cell Lymphoma Limits Sequential Therapy, Particularly after First Relapse: Patterns of Care and Outcomes in a Series from Australia and the United Kingdom.” British Journal of Haematology 204 (2): 548–54. doi:10.1111/bjh.19179.